This paper reviews how researchers are engineering exosomes to serve as targeted cancer therapies. By modifying their surface and cargo, scientists can use exosomes to deliver anti-cancer drugs, gene therapy, or immune-activating signals directly to tumor cells.

The article describes how this approach could lead to more effective treatments with fewer side effects than traditional chemotherapy. It is a forward-looking review of exosome biotechnology in oncology.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.